MedPath

Efficacy of Donepezil in the treatment of Major Depressive Disorder

Phase 3
Conditions
Major Depressive Disorder.
Sever Depressive Episode Without Psychotic Symptoms
Registration Number
IRCT2013031011885N2
Lead Sponsor
Vice chancellor for research, Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Entry: All outpatients with Major Depressive Disorder based on DSM-IV-TR in the age range of 25-55 year old who refer to psychiatric clinic in Zare hospital or Tooba clinic. Exclusion criteria: Catatonia; Acute suicidal idea; Major past medical history; Endocrine diseases; Chronic cardiovascular diseases; Respiratory diseases; Hepatic failure; Renal failure; Active peptic ulcer, Acute infectious diseases; Malignancies; Neurolgic disorders; Axis I psychiatric disorders except of Major depressive disorder; Axis II psychiatric disorders; Family history of bipolar disorder; Concomitant use of psychiatric drugs except for Antidepressants; Outside the age range of 25-55; refuse to participate in the study; Pregnancy, Breastfeeding; Lack of contraception in women of childbearing age.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Memory. Timepoint: Before intervention,End of intervention,3months after ending intervention. Method of measurement: With wechsler memory scale.;Depression. Timepoint: Before intervention,Every month for three months after beginning intervention,3months after ending intervention. Method of measurement: With hamilton depression rating scale.
Secondary Outcome Measures
NameTimeMethod
Side effects of drugs. Timepoint: 1st,2st.3st month after intervention and three month after ending intervention. Method of measurement: By filling a checklist of drug side effects.
© Copyright 2025. All Rights Reserved by MedPath